Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12077790 Optimized binuclease fusions and methods

Patent 12077790 was granted and assigned to Resolve Therapeutics on September, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 4 Sep, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 4 Sep, 2024
Edits made to:
Infobox (+80 properties)
Article (+392 characters)
‌

 US Patent 12077790 Optimized binuclease fusions and methods

Article

Patent abstract

The invention provides for optimized binuclease fusion proteins with increased pharmacokinetic properties. The optimized binuclease fusion proteins of the invention two or more nuclease domains (e.g., RNase and DNase domain) operably coupled to an Fc domain. The invention also provides methods of treating or preventing a condition associated with an abnormal immune response.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Resolve Therapeutics
Resolve Therapeutics
0
Current Assignee
Resolve Therapeutics
Resolve Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120777900
Patent Inventor Names
Chris Gabel0
James Arthur Posada0
Sanjay Patel0
Weihong Yu0
Date of Patent
September 3, 2024
0
Patent Application Number
175605220
Date Filed
December 23, 2021
0
Patent Citations
‌
US Patent 7087726 Anti-interferon-α antibodies
0
‌
US Patent 7098016 Ribonuclease zymogen design
0
‌
US Patent 7118751 DNA vaccines encoding antigen linked to a domain that binds CD40
0
‌
US Patent 7176278 Modified transferrin fusion proteins
0
‌
US Patent 7247302 Method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis
0
‌
US Patent 7317091 Optimized Fc variants
0
‌
US Patent 7364731 Polypeptide variants
0
‌
US Patent 7407785 Human DNase I hyperactive variants
0
‌
US Patent 7416875 Cytotoxic ribonuclease variants
0
‌
US Patent 7442527 Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
0
‌
US Patent 7544487 Fusion proteins containing recombinant cytotoxic RNAses
0
‌
US Patent 7608395 Systemic lupus erythematosus diagnostic assay
0
‌
US Patent 7642228 Method for making heteromultimeric polypeptides
0
‌
US Patent 7655757 Cytotoxic ribonuclease variants
0
‌
US Patent 7662925 Optimized Fc variants and methods for their generation
0
‌
US Patent 7695936 Knobs and holes heteromeric polypeptides
0
‌
US Patent 7732167 Interferon-α/β binding fusion proteins and therapeutic uses thereof
0
‌
US Patent 7749735 IFNAR2 mutants, their production and use
0
‌
US Patent 7754208 Binding domain-immunoglobulin fusion proteins
0
‌
US Patent 7754209 Binding constructs and methods for use thereof
0
‌
US Patent 7807409 Method for the recombinant expression of a polypeptide
0
‌
US Patent 7829084 Binding constructs and methods for use thereof
0
‌
US Patent 7892740 Prognosis and therapy predictive markers and methods of use
0
‌
US Patent 7910707 Anti-interferon-α antibodies
0
‌
US Patent 8029782 Therapeutic ribonucleases
0
‌
US Patent 8067548 Fusion proteins having mutated immunoglobulin hinge region
0
‌
US Patent 8133699 Minimal DNA sequence acting as a chromatin insulator and its use in protein expression
0
‌
US Patent 8158579 Fusion protein of an exendin to modified transferrin
0
‌
US Patent 8198063 Rapid deglycosylation of glycoproteins
0
‌
US Patent 8216805 Knobs and holes heteromeric polypeptides
0
‌
US Patent 8349331 Anti-interferon-α antibodies
0
‌
US Patent 8586713 Readily isolated bispecific antibodies with native immunoglobulin format
0
‌
US Patent 8642752 Modulation of Hepatitis B virus (HBV) expression
0
‌
US Patent 8679785 Knobs and holes heteromeric polypeptides
0
‌
US Patent 8697065 Non-natural ribonuclease conjugates as cytotoxic agents
0
‌
US Patent 8828393 Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist
0
‌
US Patent 8841416 Therapeutic nuclease compositions and methods
0
‌
US Patent 8871912 Engineered heterodimeric protein domains
0
‌
US Patent 8937157 Therapeutic nuclease compositions and methods
0
‌
US Patent 9150663 Heterodimeric antibody Fc-containing proteins and methods for production thereof
0
‌
US Patent 9181345 Methods of treating lupus
0
‌
US Patent 9249226 Antibodies against human CD38
0
‌
US Patent 9493570 Fixed dosage regimens for anti-type I interferon receptor (IFNAR) antibodies
0
‌
US Patent 9499634 Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells
0
‌
US Patent 9505848 Engineered heterodimeric protein domains
0
‌
US Patent 9540433 Human antibodies and antibody-drug conjugates against CD74
0
‌
US Patent 9562109 Stable heterodimeric antibody design with mutations in the Fc domain
0
‌
US Patent 9574010 Stable heterodimeric antibody design with mutations in the Fc domain
0
‌
US Patent 9636420 Polypeptide complex comprising non-peptidyl polymer having three functional ends
0
‌
US Patent 9790479 Therapeutic nuclease compositions and methods
0
‌
US Patent 9822173 Heterodimeric immunoglobulins
0
‌
US Patent 9861681 Therapeutic compositions for neutralizing type I interferons, and methods of use
0
‌
US Patent 9895433 Interferon-β production modulating
0
‌
US Patent 9919062 Oncolytic vaccinia virus cancer therapy
0
‌
US Patent 10000745 Therapeutic nuclease compositions and methods
0
‌
US Patent 10150800 EGFR-binding modular recognition domains
0
‌
US Patent 10202588 Therapeutic nuclease compositions and methods
0
‌
US Patent 10947295 Heterodimers of soluble interferon receptors and uses thereof
0
‌
US Patent 10988745 Therapeutic nuclease-albumin fusions and methods
0
‌
US Patent 11034944 Therapeutic nuclease compositions and methods
0
‌
US Patent 11306295 Heat-resistant luciferase
0
‌
US Patent 11306297 Therapeutic nuclease compositions and methods
0
‌
US Patent 6998253 Altered polypeptides with increased half-life
0
‌
US Patent 7033572 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
0
‌
US Patent 7067298 Compositions and methods of using a synthetic Dnase I
0
‌
US Patent 7074592 Secreted and transmembrane polypeptides nucleic acid encoding
0
‌
US Patent 7083784 Molecules with extended half-lives, compositions and uses thereof
0
Patent Primary Examiner
‌
Phuong Huynh
0

Find more entities like US Patent 12077790 Optimized binuclease fusions and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.